Literature DB >> 32344436

Associations of childhood adiposity with menstrual irregularity and polycystic ovary syndrome in adulthood: the Childhood Determinants of Adult Health Study and the Bogalusa Heart Study.

Y He1, J Tian1, L Blizzard1, W H Oddy1, T Dwyer1,2, L A Bazzano3, M Hickey4, E W Harville3, A J Venn1.   

Abstract

STUDY QUESTION: Is high adiposity in childhood associated with menstrual irregularity and polycystic ovary syndrome (PCOS) in later life? SUMMARY ANSWER: Overall, greater childhood BMI was associated with menstrual irregularity, and greater childhood BMI and waist/height ratio (WHtR) in white but not black participants were associated with PCOS in adulthood. WHAT IS KNOWN ALREADY: Increased childhood BMI has been associated with irregular menstrual cycles and PCOS symptoms in adulthood in two longitudinal population-based studies, but no study has reported on associations with childhood abdominal obesity. Few studies have investigated whether there are racial differences in the associations of adiposity with PCOS though there has been some suggestion that associations with high BMI may be stronger in white girls than in black girls. STUDY DESIGN, SIZE, DURATION: The study included 1516 participants (aged 26-41 years) from the Australian Childhood Determinants of Adult Health study (CDAH) and 1247 participants (aged 26-57 years) from the biracial USA Babies substudy of the Bogalusa Heart Study (BBS) who were aged 7-15 years at baseline. At follow-up, questions were asked about menstruation (current for CDAH or before age 40 years for BBS), ever having had a diagnosis of PCOS and symptoms of PCOS. PARTICIPANTS/MATERIALS, SETTING,
METHODS: In CDAH, a single childhood visit was conducted in 1985. In BBS, multiple childhood visits occurred from 1973 to 2000 and race was reported (59% white; 41% black). In childhood, overweight and obesity were defined by international age-sex-specific standards for BMI and WHtR was considered as an indicator of abdominal obesity. Multilevel mixed-effects Poisson regression estimated relative risks (RRs) adjusting for childhood age, highest parental and own education and age at menarche. MAIN RESULTS AND THE ROLE OF CHANCE: The prevalence of childhood obesity was 1.1% in CDAH and 7.5% in BBS. At follow-up, menstrual irregularity was reported by 16.7% of CDAH and 24.5% of BBS participants. The prevalence of PCOS was 7.4% in CDAH and 8.0% in BBS participants. In CDAH, childhood obesity was associated with menstrual irregularity (RR = 2.84, 95% CI: 1.63-4.96) and PCOS (RR = 4.05, 95% CI: 1.10-14.83) in adulthood. With each 0.01 unit increase in childhood WHtR there was a 6% (95% CI: 1-11%) greater likelihood of PCOS. Overall, in BBS, childhood obesity was associated with increased risk of menstrual irregularity (RR = 1.44, 95% CI: 1.08-1.92) in adulthood. Significant interaction effects between race and childhood adiposity were detected in associations with PCOS. In BBS white participants, childhood obesity was associated with PCOS (RR = 2.93, 95% CI: 1.65-5.22) and a 0.01 unit increase in childhood WHtR was associated with an 11% (95% CI: 5-17%) greater likelihood of PCOS in adulthood. In BBS black participants, no statistically significant associations of childhood adiposity measures with PCOS were observed. LIMITATIONS, REASONS FOR CAUTION: The classification of menstrual irregularity and PCOS was based on self-report by questionnaire, which may have led to misclassification of these outcomes. However, despite the limitations of the study, the prevalence of menstrual irregularity and PCOS in the two cohorts was consistent with the literature. While the study samples at baseline were population-based, loss to follow-up means the generalizability of the findings is uncertain. WIDER IMPLICATIONS OF THE
FINDINGS: Greater childhood adiposity indicates a higher risk of menstrual irregularity and PCOS in adulthood. Whether this is causal or an early indicator of underlying hormonal or metabolic disorders needs clarification. The stronger associations of adiposity with PCOS in white than black participants suggest that there are racial differences in childhood adiposity predisposing to the development of PCOS and other environmental or genetic factors are also important. STUDY FUNDING/COMPETING INTEREST(S): The CDAH study was supported by grants from the Australian National Health and Medical Research Council (grants 211316, 544923 and 1128373). The Bogalusa Heart Study is supported by US National Institutes of Health grants R01HD069587, AG16592, HL121230, HD032194 and P50HL015103. No competing interests existed.
© The Author(s) 2020. Published by Oxford University Press on behalf of the European Society of Human Reproduction and Embryology. All rights reserved. For permissions, please e-mail: journals.permission@oup.com.

Entities:  

Keywords:  BMI; childhood; menstrual irregularity; polycystic ovary syndrome; waist/height ratio

Mesh:

Year:  2020        PMID: 32344436      PMCID: PMC7259370          DOI: 10.1093/humrep/deaa069

Source DB:  PubMed          Journal:  Hum Reprod        ISSN: 0268-1161            Impact factor:   6.918


  46 in total

1.  The relationship between maternal and umbilical cord androgen levels and polycystic ovary syndrome in adolescence: a prospective cohort study.

Authors:  M Hickey; D M Sloboda; H C Atkinson; D A Doherty; S Franks; R J Norman; J P Newnham; R Hart
Journal:  J Clin Endocrinol Metab       Date:  2009-06-30       Impact factor: 5.958

2.  Assessment of menstrual regularity and irregularity using self-reports and objective criteria.

Authors:  A Weller; L Weller
Journal:  J Psychosom Obstet Gynaecol       Date:  1998-06       Impact factor: 2.949

3.  Low birth weight is associated with higher blood pressure variability from childhood to young adulthood: the Bogalusa Heart Study.

Authors:  Wei Chen; Sathanur R Srinivasan; Lu Yao; Shengxu Li; Pronabesh Dasmahapatra; Camilo Fernandez; Jihua Xu; Gerald S Berenson
Journal:  Am J Epidemiol       Date:  2012-10-01       Impact factor: 4.897

4.  Validity of self-reported menstrual cycle length.

Authors:  Chanley M Small; Amita K Manatunga; Michele Marcus
Journal:  Ann Epidemiol       Date:  2006-08-01       Impact factor: 3.797

5.  Black women with polycystic ovary syndrome (PCOS) have increased risk for metabolic syndrome and cardiovascular disease compared with white women with PCOS [corrected].

Authors:  Jennifer K Hillman; Lauren N C Johnson; Meghana Limaye; Rebecca A Feldman; Mary Sammel; Anuja Dokras
Journal:  Fertil Steril       Date:  2013-12-30       Impact factor: 7.329

6.  Relationship of upper body obesity to menstrual disorders.

Authors:  Tsutomu Douchi; Riki Kuwahata; Shinako Yamamoto; Toshimichi Oki; Hideki Yamasaki; Yukihiro Nagata
Journal:  Acta Obstet Gynecol Scand       Date:  2002-02       Impact factor: 3.636

7.  Obesity and menstrual irregularity: associations with SHBG, testosterone, and insulin.

Authors:  Shuying Wei; Michael D Schmidt; Terence Dwyer; Robert J Norman; Alison J Venn
Journal:  Obesity (Silver Spring)       Date:  2009-01-29       Impact factor: 5.002

8.  Overweight and obesity from childhood to adulthood: a follow-up of participants in the 1985 Australian Schools Health and Fitness Survey.

Authors:  Alison J Venn; Russell J Thomson; Michael D Schmidt; Verity J Cleland; Beverley A Curry; Hanni C Gennat; Terence Dwyer
Journal:  Med J Aust       Date:  2007-05-07       Impact factor: 7.738

9.  The prevalence and features of the polycystic ovary syndrome in an unselected population.

Authors:  Ricardo Azziz; Keslie S Woods; Rosario Reyna; Timothy J Key; Eric S Knochenhauer; Bulent O Yildiz
Journal:  J Clin Endocrinol Metab       Date:  2004-06       Impact factor: 5.958

10.  The prevalence of polycystic ovary syndrome in a community sample assessed under contrasting diagnostic criteria.

Authors:  Wendy A March; Vivienne M Moore; Kristyn J Willson; David I W Phillips; Robert J Norman; Michael J Davies
Journal:  Hum Reprod       Date:  2009-11-12       Impact factor: 6.918

View more
  7 in total

1.  Birthweight, Childhood Body Mass Index, Height and Growth, and Risk of Polycystic Ovary Syndrome.

Authors:  Julie Aarestrup; Dorthe C Pedersen; Peter E Thomas; Dorte Glintborg; Jens-Christian Holm; Lise G Bjerregaard; Jennifer L Baker
Journal:  Obes Facts       Date:  2021-05-12       Impact factor: 3.942

2.  Metabolic impact of current therapeutic strategies in Polycystic Ovary Syndrome: a preliminary study.

Authors:  María Victoria De Diego; Olga Gómez-Pardo; Janette Kirk Groar; Alejandro López-Escobar; Irene Martín-Estal; Inma Castilla-Cortázar; Miguel Ángel Rodríguez-Zambrano
Journal:  Arch Gynecol Obstet       Date:  2020-08-08       Impact factor: 2.344

Review 3.  Revisiting the Impact of Local Leptin Signaling in Folliculogenesis and Oocyte Maturation in Obese Mothers.

Authors:  Karolina Wołodko; Juan Castillo-Fernandez; Gavin Kelsey; António Galvão
Journal:  Int J Mol Sci       Date:  2021-04-20       Impact factor: 5.923

4.  Reply: Association of maternal polycystic ovary syndrome or anovulatory infertility with obesity and diabetes in offspring: a population-based cohort study.

Authors:  Xinxia Chen; Emilia Koivuaho; Terhi T Piltonen; Mika Gissler; Catharina Lavebratt
Journal:  Hum Reprod       Date:  2021-12-27       Impact factor: 6.918

5.  Genomic correlation, shared loci, and causal relationship between obesity and polycystic ovary syndrome: a large-scale genome-wide cross-trait analysis.

Authors:  Qianwen Liu; Zhaozhong Zhu; Peter Kraft; Qiaolin Deng; Elisabet Stener-Victorin; Xia Jiang
Journal:  BMC Med       Date:  2022-02-11       Impact factor: 8.775

6.  The effects of obesity on the menstrual cycle.

Authors:  Khalida Itriyeva
Journal:  Curr Probl Pediatr Adolesc Health Care       Date:  2022-07-21

7.  Association of maternal polycystic ovary syndrome or anovulatory infertility with obesity and diabetes in offspring: a population-based cohort study.

Authors:  Xinxia Chen; Emilia Koivuaho; Terhi T Piltonen; Mika Gissler; Catharina Lavebratt
Journal:  Hum Reprod       Date:  2021-07-19       Impact factor: 6.918

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.